Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Background/Objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this treatment. This study aims to evaluate the contribution of the intr...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Ferhat Turgut, Gábor M. Somfai, Christoph Tappeiner, Katja Hatz, Irmela Mantel, Aude Ambresin, Guy Donati, Viviane Guignard, Dana Nagyová, Isabel B. Pfister, Christine Schild, Justus G. Garweg
स्वरूप: लेख
भाषा:English
प्रकाशित: MDPI AG 2024-09-01
श्रृंखला:Pharmaceuticals
विषय:
diabetic macular edema
intravitreal dexamethasone implant
anti-VEGF
ऑनलाइन पहुंच:https://www.mdpi.com/1424-8247/17/9/1235

इंटरनेट

https://www.mdpi.com/1424-8247/17/9/1235

समान संसाधन